PharmaCyte Biotech, Inc. PMCB
0.40 USD 0.00 (-0.77%)
At closeNov 12, 2026, 4:25 AM EST
0.41 +0.01 +2.76%
Pre-market · Nov 12, 4:25 AM ET
0.25 Day range 0.4334
0.25 52-week range 1.51
- YTD
- -44.89%
- 1 year
- -54.56%
News
benzinga.com PharmaCyte Biotech Board Approves 1-For-19 Reverse Stock Split; Expected To Begin Trading On Post-Split Adjusted Basis On November 13 PharmaCyte’s common stock is expected to begin trading on a post-split adjusted basis on November 13, 2026PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company"), today announced that…
businesswire.com PharmaCyte Biotech, Inc. Announces Reverse Stock Split LAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), today announced that the board of directors of the Company approved a 1-for-19 reverse stock split…
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers MaxCyte (NASDAQ:MXCT) stock increased by 21.4% to $1.53 during Monday's pre-market session. The market value of their outstanding shares is at $130.0 million. Vir Biotechnology (NASDAQ:VIR)…